Trial Identifier: | MB102-137 |
Sponsor: | AstraZeneca |
Collaborator: |
Bristol-Myers Squibb
|
NCTID:: | NCT02096705 |
Start Date: | March 2014 |
Primary Completion Date: | January 2016 |
Condition: | Endocrine - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
China | Beijing, China, 100039 |
China | Tianjin, China |
China, BEIJING | Beijing, BEIJING, China, 100730 |
China, BEIJING | Beijing, BEIJING, China, 100029 |
China, BEIJING | Beijing, BEIJING, China, 100700 |
China, GUANGDONG | Guangzhou, GUANGDONG, China, 510120 |
China, GUANGDONG | Guangzhou, GUANGDONG, China, 510080 |
China, HEILONGJIANG | Haerbin, HEILONGJIANG, China, 150001 |
China, HUNAN | Changsha, HUNAN, China, 410000 |
China, HUNAN | Changsha, HUNAN, China, 410008 |
China, JIANGSU | Nanjing, JIANGSU, China, 210012 |
China, JIANGSU | Suzhou, JIANGSU, China, 215004 |
China, JIANGSU | Wuxi, JIANGSU, China, 214023 |
China, JILIN | Changchun, JILIN, China, 130041 |
China, SHANGHAI | Shanghai, SHANGHAI, China, 200040 |
China, SHANGHAI | Shanghai, SHANGHAI, China, 200080 |
China, SHANGHAI | Shanghai, SHANGHAI, China, 200072 |
China, SHANGHAI | Shanghai, SHANGHAI, China, 200092 |
China, Shanxi | Xi An, Shanxi, China, 710032 |
China, Shanxi | Xi'an, Shanxi, China, 710061 |
China, SICHUAN | Chengdu, SICHUAN, China, 610072 |
China, SICHUAN | Chongqing, SICHUAN, China, 400010 |
Korea, Republic of | Busan, Korea, Republic of, 49241 |
Korea, Republic of | Daegu, Korea, Republic of, 42415 |
Korea, Republic of | Daejeon, Korea, Republic of, 35233 |
Korea, Republic of | Seoul, Korea, Republic of, 06351 |
Korea, Republic of | Seoul, Korea, Republic of, 134-727 |
Singapore | Singapore, Singapore, 169856 |
Singapore | Singapore, Singapore, 529889 |